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The significance of DNA repair to human health has been
well documented by studies on xeroderma pigmentosum
(XP) patients, who suffer a dramatically increased risk of
cancer in sun-exposed areas of their skin [1,2]. This
autosomal recessive disorder has been directly
associated with a defect in nucleotide excision–repair
(NER) [1,2]. Like human XP individuals, mice carrying
homozygous mutations in XP genes manifest a
predisposition to skin carcinogenesis following exposure
to ultraviolet (UV) radiation [3–5]. Recent studies have
suggested that, in addition to roles in apoptosis [6] and
cell-cycle checkpoint control [7] in response to DNA
damage, p53 protein may modulate NER [8]. Mutations in
the p53 gene have been observed in 50 % of all human
tumors [9] and have been implicated in both the early
[10] and late [11] stages of skin cancer. To examine the
consequences of a combined deficiency of the XPC and
the p53 proteins in mice, we generated double-mutant
animals. We document a spectrum of neural tube defects
in XPC p53 mutant embryos. Additionally, we show that,
following exposure to UV-B radiation, XPC p53 mutant
mice have more severe solar keratosis and suffer
accelerated skin cancer compared with XPC mutant mice
that are wild-type with respect to p53. 
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Results and discussion
The pathogenesis of many human cancers is believed to
involve a series of sequential events, in which multiple
genes are implicated. In order to examine the conse-
quences of defective NER in the context of a mammalian
organism, as well as possible interactions between defects
in NER and in other processes that normally safeguard the
integrity of the genome, we have generated mice that are
homozygously defective in the XPC gene. A targeting
vector was constructed to replace a fragment of the mouse
genomic XPC gene containing exon 10 and a portion of
each of the flanking introns with a neomycin phospho-
transferase expression cassette. Details of the generation
of XPC mutant mice and their phenotypic characterization
with respect to defects in both global and strand-specific
NER will be reported elsewhere.
Recent studies have suggested that p53 protein may
directly or indirectly modulate the activity of cellular
DNA-repair pathways [8]. In order to examine the conse-
quences of combined defects in the p53 gene and in NER,
we crossed our XPC mutant mice with p53 mutant animals.
Crosses between mice heterozygous for both the XPC and
p53 genes generated progeny with all nine possible com-
bined genotypes. Subsequent crosses of p53 heterozygous
mice were established to compare the segregation of p53
alleles between XPC wild-type (+/+), heterozygous (+/–)
and homozygous (–/–) mutant progeny (Table 1). Consis-
tent with previous studies, inheritance of the p53 alleles
deviated from normal Mendelian segregation [12,13].
However, we detected no significant differences in the
inheritance of p53 alleles between the three different XPC
genotypic groups. Among a total of 132 XPC+/+ mice identi-
fied by genotyping, 36 (27 %) were also p53+/+, 74 (56 %)
Table 1
Inheritance of p53 alleles among XPC wild-type, heterozygous
and homozygous mutant progeny from crosses of p53
heterozygous mice. 
XPC+/+ XPC+/– XPC–/–
p53+/+ 36/132 (27 %)* 61/206 (30 %) 64/234 (27 %)
18/18† 24/37 35/29
p53+/– 74/132 (56 %) 99/206 (48 %) 129/234 (55 %)
36/38 51/48 68/61
p53–/– 22/132 (17 %) 46/206 (22 %) 41/234 (18 %)
17/5 35/11 32/9
*Inheritance of p53 alleles is expressed as a percentage of the total
number of progeny for each genotypic group of XPC. †Ratio of males
to females. XPC mutant female mice of hybrid background (50 %
129/Sv and 50 % C57Bl/6) were crossed with p53 heterozygous
male mice of the 129/Sv strain background (purchased from The
Jackson Induced Mutant Resource). Progeny identified as
heterozygous at both loci were intercrossed generating all nine
possible combinations of XPC and p53 genotypes. The resulting
hybrid strain background of 75 % 129/Sv and 25 % C57Bl/6 was
maintained in all subsequent crosses. Mutant XPC and p53 alleles
were distinguished from wild-type alleles by Southern-blot analysis.
were p53+/– and 22 (17 %) were p53–/–. Similarly, among
206 XPC+/– mice, 61 (30 %) were also p53+/+, 99 (48 %)
were p53+/– and 46 (22 %) were p53–/–. Finally, among 234
XPC–/– mice, 64 (27 %) were also p53+/+, 129 (55 %) were
p53+/– and 41 (18 %) were p53–/–. The slight but consistent
deviation from strict Mendelian segregation of p53 alleles
apparently derives from a selective loss of females among
p53–/– progeny (Table 1). Loss of female p53–/– mice has
been noted previously and results principally from neural
tube defects (primarily exencephaly) in the developing
embryo [12,13]. A recent study identified exencephaly in
20 of 106 (19 %) p53–/– female embryos [13]. Many of these
embryos also exhibited a variety of craniofacial malforma-
tions. The same study identified a single exencephalic
animal among 128 p53–/– male embryos. We observed
neural tube defects in 7 of 13 (54 %) XPC–/– p53–/– mutant
female embryos and in 1 of 14 XPC–/– p53–/– mutant male
embryos. Histological examination of four abnormal XPC–/–
p53–/– embryos revealed a variable spectrum of neural tube
abnormalities. One embryo showed exencephaly with a
complete absence of membranes surrounding extruded
brain tissue (Fig. 1a,c). A second embryo demonstrated
absence of the cranial vault and a complete lack of neural
tissue (Fig. 1d), a condition resembling anencephaly in
humans [14]. The third embryo suffered an encephalocele,
a condition in which a portion of highly disorganized neural
tissue was exposed but was surrounded by an intact mem-
brane (Fig. 1e). The intracranial neural tissue in this
embryo was also grossly disorganized. In a fourth embryo,
there was a small opening in the cranium through which a
small amount of disorganized neural tissue was extruded
(Fig. 1f). This state is strikingly similar to a variant of anen-
cephaly in humans, termed meroanencephaly [14]. Inter-
estingly, this embryo was a male, as determined by
hybridization of yolk sac DNA to a chromosome Y-specific
probe [15]. Deficiency in p53 protein is clearly implicated
in developmental abnormalities [12,13], possibly by alter-
ing normal apoptosis and cell-cycle regulation. Further
detailed studies are in progress to examine the conse-
quence of defects in the XPC gene, and in NER in general,
on the genesis of these developmental abnormalities. 
The consequences of acute skin exposure to UV-B light
were examined in adult male mice representing all nine
genotypic combinations of XPC and p53. In one experi-
ment, the shaved dorsal skin of two male adult mice of
each genotype was exposed to 1.2 kJ m–2 of UV-B radiation
per day for 7 days. In a second experiment, two other males
of each genotype were exposed to 2.1 kJ m–2 of UV-B radi-
ation per day for 7 days. Histological examination of skin
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Figure 1
Central nervous system abnormalities observed
in day 16.5 XPC–/– p53–/– embryos. (a) Gross
appearance of (from left to right) XPC–/– p53–/–,
XPC–/– p53+/– and XPC–/– p53+/+ embryos.
The XPC–/– p53–/– embryo is exencephalic.
(b–f) coronal sections of the cranial area of
XPC–/– p53–/– embryos. (b) Histological section
of an unaffected mouse embryo demonstrating
an intact cranial vault and normal symmetrical
cerebral hemispheres. (c) Histological section
showing typical exencephaly in a female XPC–/–
p53–/– animal. The brain parenchyma is
dysplastic, with no evidence of normal
hemisphere development. (d) Histological
section of a female XPC–/– p53–/– animal
showing a complete absence of brain
parenchyma, a condition resembling
anencephaly in humans. (e) Histological section
showing an encephalocele in a female XPC–/–
p53–/– embryo. Note the intact membrane
surrounding the extruded neural tissue and the
disorganization of the extracranial and
intracranial parenchyma. (f) Histological section
showing a protrusion of a small amount of neural
tissue through a tiny opening in a male XPC–/–
p53–/– embryo. This condition resembles human
meroanencephaly, a variant of anencephaly.
Magnification of embryo sections was 16×.
Crosses of XPC–/– p53+/– females with XPC–/–
p53+/– males were established to examine
13.5–18.5 day embryos for developmental
abnormalities. The sex of embryos was
determined by Southern analysis of yolk sac
genomic DNA using a hybridization probe
consisting of a 300 bp BglII–PstI fragment from
the Y chromosome-specific sry gene [15].
Embryos were fixed in 10 % buffered formalin,
paraffin embedded, sectioned and stained with
hematoxylin and eosin.
biopsies was carried out in a blinded fashion. Sections from
all XPC–/– p53+/+ mice showed increased sensitivity to irra-
diation with UV-B light, as shown by pronounced hyperk-
eratosis and epidermal hyperplasia (Fig. 2b). This response
was not observed in similarly irradiated mice that were
wild-type or heterozygous for the XPC gene, regardless of
the p53 genotype (Fig. 2a). The acute response to UV-B
light was further aggravated as a function of the p53 geno-
type in XPC–/– mice. In addition to pronounced hyperker-
atosis and epidermal hyperplasia, sections of the skin of
XPC–/– p53+/– animals showed epidermal dysplasia, as
shown by nuclear pleomorphism and the presence of
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Figure 2
Hypersensitivity to acute exposure of UV-B
radiation 24 h after seven daily doses
(2.1 kJ m–2). (a) Histological section of the
dorsal skin of an irradiated wild-type mouse.
Note the mild hyperkeratosis and epidermal
hyperplasia with absence of dysplasia. (b)
Histological section of the dorsal skin of an
irradiated XPC–/– p53+/+ mouse. Note the
marked increase in keratosis and epidermal
hyperplasia. (c) Histological section of the
dorsal skin of a UV-irradiated XPC–/– p53+/–
mouse. Note the additional presence of nuclear
pleomorphism, dyskeratosis and delayed nuclear
maturation, indicative of dysplasia; a
premalignant state. (d) Histological section of
the dorsal skin of a UV-irradiated XPC–/– p53–/–
mouse demonstrating more pronounced
dysplasia. (Magnification (255×) is the same in
all panels.) The dorsal surface of the mice was
shaved and irradiated with UV-B light (peak
310 nm, filtered through Kodacel sheeting;
Eastman Kodak) using two FS15T8 lamps (Light
Sources, Inc.) at a fluence of 5 J m–2 s–1 for
7 min (2.1 kJ m–2) or 4 min (1.2 kJ m–2) once a
day for 7 days. Mice were sacrificed 24 h after
the last day of irradiation and the dorsal skin was
dissected and fixed in 10 % buffered formalin for
24 h. Skin biopsies were embedded in paraffin,
sectioned at 5 mm and stained with hematoxylin
and eosin.
Figure 3
Accelerated skin cancer in XPC–/– p53+/– mice. 
(a) Plot comparing latency for the development of
skin cancer in XPC–/– p53+/– (red squares) and
XPC–/– p53+/+ (blue diamonds) mice. No skin
cancers were detected in any of the four other
genotypic groups tested (XPC+/+ p53+/+, XPC+/–
p53+/+, XPC+/+ p53+/– and XPC+/– p53+/– mice)
(green circles). (b) Histology of a moderately
differentiated squamous cell carcinoma (grade 2)
from a XPC–/– p53+/+ mouse. Note the
incompletely keratinized centers. (c) Histology of a
poorly differentiated squamous cell carcinoma
(grade 4) from a XPC–/– p53+/– mouse. No
evidence of keratinization is present. Tumor cells
are atypical, spindle shaped and have few
recognizable intercellular bridges. Magnification of
tumor sections was 160×. Six groups of mice
consisting of 10 animals (5 males and 5 females)
per group were treated with 1.2 kJ m–2 of UV-B
each day for up to 22 weeks. The dorsal skin was
shaved weekly or as required. Mice were examined
weekly for hypersensitivity to UV radiation and skin
cancer. UV treatments were stopped in XPC–/–
p53+/– mice at 16 weeks (100 % incidence of skin
cancer). Treatments were continued in the five
other groups of mice until 22 weeks. Mice were
sacrificed and autopsied and tissue was
processed for histological examination as
described in Fig. 2.
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mitotic figures (Fig. 2c). Dysplasia was more pronounced in
sections from XPC–/– p53–/– animals (Fig. 2d). In summary,
solar keratosis following acute skin exposure to UV-B radia-
tion was observed in XPC–/– p53+/+ animals and worsened
progressively in XPC–/– p53+/– or XPC–/– p53–/– mice.
Mice that are homozygous mutant in the XPA and XPC
genes have a significant predisposition to UV radiation-
induced skin cancer [3–5]. We treated six genotypic
groups of mice (10 animals per group, 5 males and 5
females) comprising XPC+/+, XPC+/– and XPC–/– animals
that were either p53+/+ or p53+/– with 1.2 kJ m–2 of UV-B
radiation per day for up to 22 weeks. Within 2 weeks of
treatment, all XPC–/– p53+/+ and XPC–/– p53+/– mice
showed marked atrophy of the ears and a hypersensitivity
response in the shaved region of skin. The response con-
sisted of erythema followed by scaling and ulceration of
the skin, which was subsequently surrounded by adherent
hyperkeratotic lesions. The size of the affected area and
the severity of the response was more pronounced in
XPC–/– p53+/– than in XPC–/– p53+/+ mice. After 8 weeks of
treatment, corneal opacity was observed in the XPC–/–
p53+/– mice and later in some XPC–/– p53+/+ animals. None
of the other four groups (XPC+/+ p53+/+, XPC+/– p53+/+,
XPC+/+ p53+/– and XPC+/– p53+/–) demonstrated hypersen-
sitivity to UV radiation. Skin tumors appeared in the
XPC–/– p53+/– mice between 8 and 9 weeks of treatment
(Fig. 3a). At 16 weeks, all 10 such animals had skin cancer
and exposure was discontinued. In contrast, the first skin
tumors in XPC–/– p53+/+ mice only appeared at 16 weeks
(Fig. 3a) and it took 22 weeks for 9 of the 10 mice in this
group to develop skin cancer (Fig. 3a). No tumors were
detected in any of the other four groups of mice (Fig. 3a). 
Skin tumors were examined histologically and graded in a
blinded fashion. Tumors from the XPC–/– p53+/+ mice
ranged from carcinoma in situ, to well differentiated squa-
mous cell carcinoma (grade 1), to moderately differentiated
squamous cell carcinoma (grade 2) (Fig. 3b). Tumors from
XPC–/– p53+/– mice were more aggressive, ranging from
well differentiated squamous cell carcinoma (grade 1), to
poorly differentiated squamous cell carcinoma (grade 4)
(Fig. 3c). Sections also showed focal areas of hyperplasia,
hyperkeratosis and mild to severe dysplasia. Hyperplasia
and dysplasia in corneal epithelium correlated with animals
in which corneal opacity was observed. In summary, XPC–/–
p53+/– mice demonstrated an aggravated response to UV-B
radiation and a significantly shorter latency in the develop-
ment of skin cancer than XPC–/– p53+/+ mice. High-grade
squamous cell carcinoma has not been previously docu-
mented in UV radiation-induced skin tumors in XPA or
XPC mutant mice. This feature apparently correlates with
the p53 heterozygous status. Chronic exposure of p53–/–
mice that are also XPC+/+, XPC+/– or XPC–/– is in progress.
Preliminary results indicate an even more extreme cancer
predisposition in XPC–/– p53–/– mice. 
Our studies document an interaction of the XPC and p53
genes with respect to cellular responses to acute and
chronic exposure to UV-B radiation. Additionally, there
are suggestions of a synergistic interaction between these
two genes with respect to normal embryogenesis. Future
studies will focus on these interactions, with a particular
emphasis of the role of the XPC and p53 genes in the
pathogenesis of environmental carcinogenesis.
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